Log In
BCIQ
Print this Print this
 

Vascular endothelial growth factor (VEGF)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Vascular endothelial growth factor (VEGF)

BCIQ
Print ChartPrint this
1 7 2 1 4 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 3 10 1 6 6 1 0 2
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Cancer

0

3

10

1

6

6

1

0

2

Hematology

0

0

0

0

1

0

0

0

0

Neurology

1

1

0

0

0

0

0

0

0

Ophthalmic

1

7

2

1

4

1

0

1

0




 Products Targeting Vascular endothelial growth factor (VEGF)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$3,529.8M

$7.2M

$3,983.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today